로딩 중…
지수 로딩 중…
Vaxcyte, Inc.
PCVX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$53.53-1.02%
2026-08-03
Financials
Valuation Metrics
Vaxcyte, Inc.'s Market Cap is $7.73B. At end of 2025 it was $6.28B. Ranked #1079 of 3,111 in US market (top 35%), #356 of 1,445 on NASDAQ (top 25%), #59 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 22%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $7.73B | US#1,079/3,111 Sec#59/269 |
| Revenue | $0.00 | US#2,980/3,111 Sec#205/269 |
| Net Income | $-947M | US—/3,111 Sec—/269 |
| Total Assets | $3.35B | US#1,733/3,111 Sec#43/269 |
| Net Assets | $3.00B | US#981/3,111 Sec#37/269 |
| Value | ||
| P/B | 2.58x | US#1,531/3,111 Sec#75/269 |
| FCF Yield | -9.98% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROE | -31.59% | US#2,630/3,111 Sec#131/269 |
| ROA | -28.27% | US#2,869/3,111 Sec#158/269 |
| Financial Health | ||
| Debt Ratio | 11.76% | US#133/3,111 Sec#57/269 |
| Total Debt | $116M | US#2,370/3,111 Sec#112/269 |
| FCF | $-772M | US#2,880/3,111 Sec#267/269 |
| Cash | $261M | US#1,528/3,111 Sec#95/269 |
| Current Ratio | 7.49x | US#311/3,111 Sec#104/269 |
| Performance | ||
| 1Y Return | 62.11% | US#586/3,111 Sec#110/269 |
| 1M Return | -8.32% | US#1,971/3,111 Sec#135/269 |
| From 52W High | -17.65% | US#1,457/3,111 Sec#98/269 |
| 1Y MDD | -27.95% | US#1,234/3,111 Sec#76/269 |
| Trading | ||
| Volume | 743,310 shares | US#1,702/3,111 Sec#162/269 |
| Trading Value | $40M | US#1,469/3,111 Sec#93/269 |
| Per Share | ||
| EPS | $-5.63 | US—/3,111 Sec—/269 |
| BPS | $19.73 | US#1,218/3,111 Sec#34/269 |